IJCEMR

Article http://dx.doi.org/10.26855/ijcemr.2022.04.004

Research Progress of Traditional Chinese Medicine in Preventing and Treating Ventricular Remodeling by Intervening RAAS System

TOTAL VIEWS: 5885

Miao Pang1,*, Liqin Zhi2

1Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.

2Xi'an Fifth Hospital, Xi'an, Shaanxi, China.

*Corresponding author: Miao Pang

Published: March 8,2022

Abstract

Chronic heart failure is a series of clinical syndromes in which a variety of cardiovascular diseases develop to the end-stage. Renin-angiotensin-aldosterone system (RAAS) plays an important role in the pathological development of chronic heart failure, especially its influence on ventricular remodeling, which is the cause of further occurrence and development of a variety of cardiovascular diseases. With the aggravation of aging in China, the population of ventricular remodeling caused by various cardiovascular diseases has increased rapidly in recent years. The incidence of a series of cardiovascular diseases caused by ventricular remodeling is also greatly increased. RAAS system through the intervention of traditional Chinese medicine, regulate the angiotensin Ⅱ (Ang Ⅱ), aldosterone (ALD) and so on to improve ventricular remodeling of chronic heart failure to control the research of the progress of heart failure have certain progress, the author collected in recent years through the intervention of traditional Chinese medicine prevention and treatment of ventricular remodeling RAAS system to prevent a series of research achievements of the occurrence of cardiovascular disease, including compound preparations and single herbs from different phase of the intervention of RAAS system mechanism, and the prevention and treatment of ventricular reconstruction by intervention RAAS system of traditional Chinese medicine and its cause of diseases of the cardiovascular system made a summary and outlook.

References

[1] Carmen, Hernández-Prats, Elsa, López-Pintor, Blanca, Lumbreras. Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: A systematic review of randomized trials and non-randomized intervention studies [J]. Research in social & administrative pharmacy: RSAP, 2021. DOI:10.1016/j.sapharm.2021.06.023.

[2] Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats [J]. Chinese Medical Journal, 2007, 120(1): 22-29.

[3] Use of Qishen granule for the treatment of heart failure: A systematic review and meta-analysis of animal studies [J]. Journal of Traditional Chinese Medicine, 2020, 7(2): 121-132.

[4] Giuseppe, Vergaro, Alberto, Aimo, Concetta, Prontera, Nicolò, Ghionzoli, Chiara, Arzilli, Luc, Zyw, Claudia, Taddei, Alessandra, Gabutti, Roberta, Poletti, Alberto, Giannoni, Chiara, Mammini, Valentina, Spini, Claudio, Passino, Michele, Emdin. (2019). Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction [J]. International journal of cardiology, 2019, 296: 91-97.

[5] Jay N, Cohn. (2010). Role of the renin-angiotensin system in cardiovascular disease [J]. Cardiovascular drugs and therapy, 2010, 24(4): 341-4. DOI: 10.1007/s10557-010-6230-3. 023.

[6] S. Fujita, M. Endoh. (1996). Effects of endothelin-1 on [Ca2+]i-shortening trajectory and Ca2+ sensitivity in rabbit single ventricular cardiomyocytes loaded with indo-1/AM: comparison with the effects of phenylephrine and angiotensin II [J]. Journal of cardiac failure, 1996, 2(4 Suppl): S45-57. DOI: 10.1016/s1071-9164(96)80058-3.

[7] Sarensa Palikhey Shrestha. (2013). Limited value of NT-pro BNP in patients with Peripartum Cardiomyopathy [D]. Huazhong University of Science and Technology, 2013.

[8] Zhouyunfeng. (2014). Induction of Cytochrome P450 4A14 is associated with Angiotensin–induced Renal Fibrosis in Mice [C]. Papers of the 24th National Congress of Chinese Physiological Society and physiology Academic Conference, 2014.

[9] Kun, Huang, Lu, Gao, Ming, Yang, Jiliang, Wang, Zheng, Wang, Lin, Wang, Guobin, Wang, Huili, Li. (2017). Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin Ⅱ-Induced hypertrophy [J]. The international journal of biochemistry & cell biology, 2017, 89: 6-15.DOI:10.1016/j.biocel.2017.05.020.

[10] Shixun, Wang, Jingtao, Xu, Jiahui, Zheng, Xincai, Zhang, Jingbo, Shao, Luyan, Zhao, Junqiang, Hao. (2020). Anti-Inflammatory and Antioxidant Effects of Acetyl-L-Carnitine on Atherosclerotic Rats [J]. Medical science monitor: international medical journal of experimental and clinical research, 2020, 26: e920250. DOI: 10.12659/MSM.920250.

[11] Shidazhuo, Liujiangang, Dongguoju. (2003). Therapeutic Mechanism of Yuxingeng Liquid on Early Ventricular Remodeling with Acute Myocardial Infarction in Rats [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2003, 9(3): 215-218.

[12] Wessel L, du Toit, Aletta E, Schutte, Lebo F, Gafane-Matemane, Ruan, Kruger, Catharina M C, Mels. The renin-angiotensin-system and left ventricular mass in young adults: the African-PREDICT study [J]. Blood pressure, 2021, 30(2): 98-107. DOI:10.1080/08037051.2020.1831902.

[13] Bertram, Pitt. (2002). Do diuretics and aldosterone receptor antagonists improve ventricular remodeling? [J]. Journal of cardiac failure, 2002, 8(6 Suppl): S491-3. DOI: 10.1054/jcaf.2002.130014.

[14] Yidong, Wei, Xiaoyu, Liu, Lei, Hou, Wenliang, Che, Erlinda, The, Muktanand Vikash, Jhummon. (2012). Qiliqiangxin affects L type ca(2+) current in the normal and hypertrophied rat heart [J]. Evidence-based complementary and alternative medicine: eCAM, 2012, 2012:131830.DOI:10.1155/2012/131830.

[15] Rong-Rong, Gao, Xiao-Dong, Wu, Hui-Min, Jiang, Yu-Jiao, Zhu, Yan-Li, Zhou, Hai-Feng, Zhang, Wen-Ming, Yao, Yong-Qin, Li, Xin-Li, Li. (2018). Traditional Chinese medicine Qiliqiangxin attenuates phenylephrine-induced cardiac hypertrophy via upregulating PPARγ and PGC-1α [J]. Annals of translational medicine, 2018, 6(8): 153.DOI:10.21037/atm.2018.04.14. 

[16] Liang, Y., Ye, Y., Ge, J., Wu, Y., Zhou, N., Gong, H., Li, L., Li, Y., Wu, J., Zou, Y., Lin, L., Zhou, J., Wei, J., Jia, Z. (2012). Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice [J]. Journal of cardiovascular pharmacology, 2012, 59(3): 268-280.

[17] A novel mitochondrial tRNA gene mutation in a chinese family with dilated cardiomyopathy and sensorineural deafness [J]. Journal of Nanjing Medical University, 2006, 20(5): 279-282.

[18] Role of hepatitis C virus in myocarditis and cardiomyopathies [J]. Journal of Geriatric Cardiology, 2004, 1(2): 83-89.

[19] Xiaoping, Wang, Hui, Meng, Qixin, Wang, Mingyan, Shao, Wenji, Lu, Xu, Chen, Yong, Jiang, Chun, Li, Yong, Wang, Pengfei, Tu. (2020). Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats [J]. Journal of ethnopharmacology, 2020, 252: 112536. DOI: 10.1016/j.jep.2019.112536.

[20] Jér me Kalifa. (2013). Atrial Coronary Perfusion and Atrial Fibrillation: Insights from experimental models [C]. Proceedings of the 7th Beijing Five Continents Conference on Cardiovascular Diseases. 2013: 17.

[21] Characteristics and Advantages of Traditional Chinese Medicine in the Treatment of Acute Myocardial Infarction [J]. Journal of traditional Chinese medicine, 2011, 31(4): 269-272.

[22] Xiao-Ning Sun, Yan Zhang, Ai-Song Zhu, Fan-Da Kong, Wei Zhang, Yao Xu. Yiqi Huoxue traditional Chinese decoction affect ventricular remodeling in rats with heart failure after myocardial infarction by regulating osteopontin expression [J]. Journal of Hainan Medical University, 2020, 26(17): 17-22.

[23] Effects of Tribuli Saponins on Left Ventricular Remodeling after Acute Myocardial Infarction in Rats with Hyperlipidemia [J]. Chinese Journal of Integrated Traditional and Western Medicine, 2005, 11(2): 142-146. 

[24] Li-Li, Hong, Yan, Zhao, Chen-Yu, Yang, Guo-Zhuang, Li,Hong-Song, Wang, Wei-Dong, Chen, Xiao-Yu, Cheng, Li, Liu. Identification of chemical constituents in vitro and in vivo of Er Shen Zhenwu Decoction by utilizing ultra-high-performance liquid chromatography with quadrupole time-of-flight mass spectrometry [J]. Journal of separation science, 2021, 44(24): 4327-4342. DOI:10.1002/jssc.202100624.

How to cite this paper

Research Progress of Traditional Chinese Medicine in Preventing and Treating Ventricular Remodeling by Intervening RAAS System

How to cite this paper: Miao Pang, Liqin Zhi. (2022) Research Progress of Traditional Chinese Medicine in Preventing and Treating Ventricular Remodeling by Intervening RAAS System. International Journal of Clinical and Experimental Medicine Research6(2), 125-130.

DOI: http://dx.doi.org/10.26855/ijcemr.2022.04.004